Our laboratory and others have explored the role of purinergic receptors in HIV-1 infection and have reported that purinergic receptor antagonists can block HIV-1 infection and reduce inflammatory cytokine production associated with infection [96,106,107]. Here, P2RY1 is linked to HIV-1 infection.